CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26188991 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Greisha L Ortiz-Hernández und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Sciences, Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute of City of Hope, Duarte, CA 9…. Hauptthemen laut MEDLINE: Cysteine-Rich Protein 61, Insulin-Like Growth Factor I, Prostatic Neoplasms, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Burroughs Wellcome Fund Postdoctoral Enrichment Program, American Cancer Society-Fred Ross Desert Spirit Postdoctoral Fellowship.
Abstract (Originalsprache)
Cysteine-rich angiogenic inducer 61 (CYR61) promotes prostate cancer (PCa) cell growth, but its role in disease progression remains unclear. Given its insulin-like growth factor (IGF)-binding domain and the known involvement of insulin-like growth factor-1 (IGF1) in PCa, we investigated the molecular interplay between CYR61 and IGF1. CYR61 was silenced using small interfering RNA (siRNA) in prostate carcinoma 3 (PC3), lymph node carcinoma of the prostate (LNCaP), and androgen receptor (AR)-positive 22Rv1 cells, followed by assessments of their proliferation, viability, colony formation, migration, and signaling pathway activation. CYR61 knockdown significantly reduced cell growth, viability, prostasphere formation, and migration across all three cell lines. Mechanistically, CYR61 silencing inhibited PI3K/AKT signaling but had no effect on MAPK activation. In addition, treatment with recombinant IGF1 induced CYR61 expression in a time-dependent manner, and the inhibition of PI3K/AKT signaling suppressed both CYR61 expression and cell proliferation. These findings suggest that IGF1 promotes PCa progression through CYR61 and that CYR61 may serve as a potential therapeutic target for limiting tumor growth and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Population Sciences, Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
- Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
ORCID-Profile: Greisha L Ortiz-Hernández, Carmina Patrick, Stefan Hinz, Yun R Li
Förderung
- NCI NIH HHS
- Burroughs Wellcome Fund Postdoctoral Enrichment Program
- American Cancer Society-Fred Ross Desert Spirit Postdoctoral Fellowship
- NIH HHS
- NIH HHS/United States and the Burroughs Wellcome Fund Postdoctoral Enrichment Program
- American Cancer Society—Fred Ross Desert Spirit Postdoctoral Fellowship
Zitieren
APA
Ortiz-Hernández, G. L., Patrick, C., Hinz, S., LaBarge, M. A., Li, Y. R., & Neuhausen, S. L. (2025). CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188991
Vancouver
Ortiz-Hernández GL, Patrick C, Hinz S, LaBarge MA, Li YR, Neuhausen SL. CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188991
BibTeX
@article{OrtizHernndez2025,
author = {Ortiz-Hernández, Greisha L and Patrick, Carmina and Hinz, Stefan and LaBarge, Mark A and Li, Yun R and Neuhausen, Susan L},
title = {CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26188991}
}
EUVIMED